Literature DB >> 32279293

Familial Interstitial Lung Disease.

Jonathan A Kropski1,2,3.   

Abstract

The interstitial lung diseases (ILDs) are a group of progressive disorders characterized by chronic inflammation and/or fibrosis in the lung. While some ILDs can be linked to specific environmental causes (i.e., asbestosis, silicosis), in many individuals, no culprit exposure can be identified; these patients are deemed to have "idiopathic interstitial pneumonia" (IIP). Family history is now recognized as the strongest risk factor for IIP, and IIP cases that run in families comprise a syndrome termed "familial interstitial pneumonia" (FIP). Mutations in more than 10 different genes have been implicated as responsible for disease in FIP families. Diverse ILD clinical phenotypes can be seen within a family, and available evidence suggests underlying genetic risk is the primary determinant of disease outcomes. Together, these FIP studies have provided unique insights into the pathobiology of ILDs, and brought focus on the unique issues that arise in the care of patients with FIP. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2020        PMID: 32279293      PMCID: PMC7272214          DOI: 10.1055/s-0040-1708054

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  138 in total

1.  SFTPA2 Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia.

Authors:  Coline H M van Moorsel; Liesbeth Ten Klooster; Matthijs F M van Oosterhout; Pim A de Jong; Human Adams; H Wouter van Es; Henk J T Ruven; Joanne J van der Vis; Jan C Grutters
Journal:  Am J Respir Crit Care Med       Date:  2015-11-15       Impact factor: 21.405

2.  A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy.

Authors:  Lisa R Young; Gail H Deutsch; Ronald E Bokulic; Alan S Brody; Lawrence M Nogee
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

3.  Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs.

Authors:  William E Lawson; Dong-Sheng Cheng; Amber L Degryse; Harikrishna Tanjore; Vasiliy V Polosukhin; Xiaochuan C Xu; Dawn C Newcomb; Brittany R Jones; Juan Roldan; Kirk B Lane; Edward E Morrisey; Michael F Beers; Fiona E Yull; Timothy S Blackwell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

4.  Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs.

Authors:  Ruping Chen; Kexiong Zhang; Hao Chen; Xiaoyin Zhao; Jianqiu Wang; Li Li; Yusheng Cong; Zhenyu Ju; Dakang Xu; Bryan R G Williams; Jihui Jia; Jun-Ping Liu
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

5.  Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.

Authors:  Michael F Beers; Lars Knudsen; Yaniv Tomer; Julian Maronn; Ming Zhao; Matthias Ochs; Surafel Mulugeta
Journal:  Ann Anat       Date:  2016-12-26       Impact factor: 2.698

6.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

7.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Authors:  Yongyu Wang; Phillip J Kuan; Chao Xing; Jennifer T Cronkhite; Fernando Torres; Randall L Rosenblatt; J Michael DiMaio; Lisa N Kinch; Nick V Grishin; Christine Kim Garcia
Journal:  Am J Hum Genet       Date:  2008-12-18       Impact factor: 11.025

8.  Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.

Authors:  Nadia Nathan; Violaine Giraud; Clément Picard; Hilario Nunes; Florence Dastot-Le Moal; Bruno Copin; Laurie Galeron; Alice De Ligniville; Nathalie Kuziner; Martine Reynaud-Gaubert; Dominique Valeyre; Louis-Jean Couderc; Thierry Chinet; Raphaël Borie; Bruno Crestani; Maud Simansour; Valérie Nau; Sylvie Tissier; Philippe Duquesnoy; Lamisse Mansour-Hendili; Marie Legendre; Caroline Kannengiesser; Aurore Coulomb-L'Hermine; Laurent Gouya; Serge Amselem; Annick Clement
Journal:  Hum Mol Genet       Date:  2016-01-19       Impact factor: 6.150

9.  Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.

Authors:  Marie Eve Brault; Catherine Lauzon; Chantal Autexier
Journal:  Hum Mol Genet       Date:  2013-05-08       Impact factor: 6.150

10.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

View more
  3 in total

1.  The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis.

Authors:  Jiurong Liang; Guanling Huang; Xue Liu; Forough Taghavifar; Ningshan Liu; Yizhou Wang; Nan Deng; Changfu Yao; Ting Xie; Vrishika Kulur; Kristy Dai; Ankita Burman; Simon C Rowan; S Samuel Weigt; John Belperio; Barry Stripp; William C Parks; Dianhua Jiang; Paul W Noble
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

2.  Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family.

Authors:  Deborah Dos Reis Estrella; Eliane Viana Mancuzo; Ricardo de Amorim Corrêa
Journal:  J Bras Pneumol       Date:  2021-12-15       Impact factor: 2.624

Review 3.  Telomeres in Interstitial Lung Disease.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.